Julianne Orr, PharmD: Biosimilars Still a Gray Area for Pharmacists

Transcript:

What is your understanding of the use of biosimilars?

I know it’s a hot topic; I know I’ve been to quite a few [continuing education sessions, CEs] on it. At [Indiana University] it has not been necessarily a big topic of discussion. We have pretty much stuck with the products we’ve been using. But I think in the future, hopefully with more knowledge of biosimilars and everything we can kind of define a clear cut “when we should use what,” and how we interchange those products. It’s definitely a gray area at the moment.